Intrinsiqq
PepGen Inc. logo

PepGen Inc. Insider Trading

PEPG

Compare
Last 12 months

Insiders sold 59K and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in May 2025.

Net open-market
−59K
0 buys · 4 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
0 / 4
executives and directors
Last open-market buy
May 2025
May 30, 2025

Get an email when PEPG's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 13
    RA Capital Management, L.p.
    Large holder · bought 8,625,000 at $5.00
    $43.1M
    46% of stake
  • May 2110b5-1 plan
    Kasra Kasraian
    Chief Technical Officer · sold 1,233 at $1.41
    2K
    2.4% of stake
  • Mar 410b5-1 plan
    Paul Streck
    EVP, Head of R&D · sold 1,879 at avg $6.23
    12K
    2.4% of stake
  • Mar 410b5-1 plan
    Noel Donnelly
    Chief Financial Officer · sold 2,084 at avg $6.23
    13K
    1.8% of stake
  • Mar 410b5-1 plan
    James G McArthur
    President and CEO · sold 5,275 at avg $6.23
    33K
    1.7% of stake
  • Sep 30, 2025
    Oxford Science Enterprises Plc
    Large holder · bought 200,000 at $3.20
    640K
    4.2% of stake
  • Sep 26, 2025
    RA Capital Healthcare Fund LP
    Large holder · bought 9,375,000 at $3.20
    $30M
    102% of stake
  • May 30, 2025
    Paul Streck
    EVP, Head of R&D · bought 8,375 at $1.24
    10K
    43% of stake
  • Apr 17, 2025
    James G McArthur
    President and CEO · bought 10,000 at $1.36
    14K
    9.6% of stake
  • Apr 8, 2025
    James G McArthur
    President and CEO · bought 41,500 at $1.15
    48K
    66% of stake
  • Feb 26, 202510b5-1 plan
    Mary Beth Delena
    General Counsel · sold 1,432 at $1.68
    2K
    48% of stake
  • Feb 26, 202510b5-1 plan
    Noel Donnelly
    Chief Financial Officer · sold 1,527 at $1.68
    3K
    48% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PEPG, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PEPG

CompareIntrinsic value
UPBUpstream Bio, Inc.
$1.59-20.50%21
OVIDOvid Therapeutics Inc.
$2.20-5.98%10
LQDALiquidia Corporation
$54.43-3.88%63
PCRXPacira BioSciences Inc.
$36.48+0.00%61
SRPTSarepta Therapeutics Inc.
$13.33-5.93%58
ETONEton Pharmaceuticals Inc.
$60.85-0.83%75
ZBIOZenas BioPharma, Inc.
$23.85-4.75%10
AGIOAgios Pharmaceuticals Inc.
$27.60-4.03%40

Held by ETFs

PEPG is in 5 US ETFs. The largest of them, with PEPG's weight in each:

Spot a number that looks wrong? Check it in PEPG's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PEPG

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.